Polypoidal Choroidal Vasculopathy
📧 Sign up to get email alerts when something new happens for Polypoidal Choroidal Vasculopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO) [Phase 4]
Phase 4 clinical trial update investigating the efficacy, safety and durability of faricimab in Caucasian patients with polypoidal choroidal…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)
This completed clinical trial update reports on long-term outcomes, recurrence rates, and treatment needs in polypoidal choroidal vasculopat…
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Adjunct Episcleral Brachytherapy for PCV [Phase 3]
Phase 3 clinical trial update for adjunct episcleral brachytherapy in polypoidal choroidal vasculopathy and age-related macular degeneration…
-
CLINICAL_TRIALS trial_result · 2022-12-12Clinical Trial Update: Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy [Phase 1, Phase 2]
A safety-focused clinical trial update for 2.0 mg Lucentis in polypoidal choroidal vasculopathy (Phase 1/2) with completed status and result…
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy [Phase 4]
Phase 4 open-label study assessing aflibercept monotherapy for polypoidal choroidal vasculopathy, completed with posted results in 2021.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy [Phase 4]
Phase 4 clinical trial update evaluating two regimens of anti-VEGF therapy for polypoidal choroidal vasculopathy in Chinese patients, focusi…
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy [Phase 4]
Phase 4 randomized trial comparing intravitreal aflibercept monotherapy to aflibercept with adjunctive photodynamic therapy in polypoidal ch…
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy [Phase 4]
A Phase 4 clinical trial update investigating intraocular cytokine therapy for recurrence of polypoidal choroidal vasculopathy, associated w…
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy [Phase 2, Phase 3]
A phase 2/3 clinical trial investigating double-dose ranibizumab for polypoidal choroidal vasculopathy was terminated.
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: Initial Versus Delayed PDT Combination With Conbercept in PCV [Phase 4]
Phase 4 trial comparing initial versus delayed photodynamic therapy (PDT) in combination with conbercept for polypoidal choroidal vasculopat…
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT) [Phase 4]
Phase 4 trial comparing ranibizumab monotherapy versus ranibizumab combined with verteporfin photodynamic therapy for symptomatic macular po…
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy [Phase 4]
Phase 4 trial comparing intravitreal ranibizumab with triamcinolone acetonide (TA) combination therapy versus ranibizumab alone for polypoid…
-
CLINICAL_TRIALS trial_result · 2018-09-05Clinical Trial Update: Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy [Phase 4]
A Phase 4 trial assessing the efficacy and safety of an intravitreal VEGF trap-eye in patients with polyploidal choroidal vasculopathy (PCV)…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen [NA]
Completed clinical trial comparing photodynamic therapy (verteporfin), intravitreal ranibizumab, and their combination for polypoidal choroi…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment [NA]
This trial update reports on visual acuity outcomes in patients with polypoidal choroidal vasculopathy treated with aflibercept, in a comple…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2) [Phase 1, Phase 2]
An investigator-sponsored Phase 1/2 trial evaluating high-dose ranibizumab for polypoidal choroidal vasculopathy has completed. Results were…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Phase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polypoid Choroidal Vasculopathy [Phase 4]
Phase IV extension study (STAR Study) of Conbercept ophthalmic injection for polypoidal choroidal vasculopathy is underway, with the current…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV) [Phase 4]
Phase 4 clinical trial evaluating the efficacy of intravitreal Conbercept for polypoidal choroidal vasculopathy.
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation [Phase 4]
Phase 4 clinical trial evaluating intravitreal aflibercept injection for polypoidal choroidal vasculopathy with hemorrhage or exudation has …
-
CLINICAL_TRIALS trial_result · 2016-08-12Clinical Trial Update: Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose [Phase 4]
Phase 4 clinical trial update comparing photodynamic therapy plus ranibizumab versus ranibizumab alone in persistent polypoidal choroidal va…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy
Clinical trial update assessing the short-term efficacy of intravitreal aflibercept in subtypes of Polypoidal Choroidal Vasculopathy (polypo…
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy [Phase 4]
Phase 4 trial evaluating intravitreal VEGF Trap-Eye (aflibercept) for polypoidal choroidal vasculopathy and exudative age-related macular de…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) [Phase 1]
This document reports the completion of a Phase 1 trial evaluating ranibizumab for polypoidal choroidal vasculopathy.
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial) [Phase 4]
Phase 4 clinical trial update on intravitreal aflibercept (Eylea) for neovascular polypoidal choroidal vasculopathy (RIVAL trial).
-
CLINICAL_TRIALS trial_result · 2014-06-23Clinical Trial Update: Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy [Phase 1, Phase 2]
Clinical trial update for ranibizumab (Lucentis) investigating treatment of polypoidal choroidal vasculopathy across Phase 1 and Phase 2, wi…